Talis Biomedical Corporation Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GREENLIGHT CAPITAL INC | 08/14/2023 | 2.24 M | $1.07 M | 0.00% | 0.56% |
| VANGUARD GROUP INC | 08/14/2023 | 466,336 | $223,841 | -1.08% | 0.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/11/2023 | 140,530 | $67,454 | -2.69% | 0.03% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2023 | 91,463 | $43,902 | -44.12% | 0.02% |
| BLACKROCK INC. | 08/11/2023 | 76,307 | $36,628 | -7.47% | 0.02% |
| MORGAN STANLEY | 08/14/2023 | 61,857 | $29,691 | 1.64% | 0.02% |
| RENAISSANCE TECHNOLOGIES LLC | 08/11/2023 | 54,900 | $26,000 | 29.18% | 0.01% |
| TWO SIGMA SECURITIES, LLC | 08/14/2023 | 49,007 | $23,523 | 100.00% | 0.01% |
| STATE STREET CORP | 08/14/2023 | 47,436 | $22,769 | -4.24% | 0.01% |
| DEUTSCHE BANK AG\ | 08/14/2023 | 45,294 | $21,741 | -24.66% | 0.01% |
| CITADEL ADVISORS LLC | 08/14/2023 | 38,876 | $18,660 | 100.00% | 0.01% |
| CITADEL ADVISORS LLC | 08/14/2023 | 27,900 | $13,392 | 100.00% | 0.01% |
| NORTHERN TRUST CORP | 08/11/2023 | 27,860 | $13,373 | 0.00% | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/11/2023 | 10,476 | $5,028 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/21/2023 | 1,564 | $751 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/14/2023 | 273 | $131 | 100.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 08/03/2023 | 200 | $96 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/15/2023 | 174 | $84 | 4.19% | 0.00% |
| UBS GROUP AG | 08/11/2023 | 26 | $12 | 0.00% | 0.00% |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | 08/02/2023 | 10 | $5 | 0.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BAKER BROS. ADVISORS LP | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Talis Biomedical Corporation institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Talis Biomedical Corporation. The most heavily invested institutionals were:
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 138,917
Amalgamated Financial Corp.: 1,803
PICTET ASSET MANAGEMENT LTD: 33,845
0.83% of Talis Biomedical Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 174,565 shares in the last 24 months. This purchase volume represents approximately $312,471 in transactions.